From: HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Variable | N° of pts/Tot pts | SVR (%) | P value |
---|---|---|---|
Sex | |||
F | 68/145 | 46 | ns |
M | 119/243 | 49 | |
Age | |||
< 50 | 123/210 | 58 | 0.00001 |
> 50 | 64/178 | 37 | |
BMI | |||
< 25 | 145/280 | 51 | 0.05 |
> 25 | 32/82 | 39 | |
ALT | |||
< 100 | 139/261 | 53 | 0.002 |
> 100 | 51/127 | 40 | |
HCV-RNA | |||
≤ 5 .60 log10 | 64/96 | 66 | 0.00004 |
> 5 .60 log10 | 123/292 | 42 | |
Genotype | |||
1a | 91/165 | 55 | 0.02 |
1b | 96/223 | 43 | |
Staging* | |||
≤ S3 | 142/262 | 54 | 0.00008 |
> S3 | 15/60 | 25 | |
Drug | |||
PegINF α 2b | 100/195 | 51 | ns |
PegINF α 2a | 87/193 | 45 | |
RVR | |||
Yes | 129/160 | 80 | 0.000001 |
No | 58/228 | 25 |